Core Scientific shares are down 4.15% to $15.04 amid a broader risk-off tape in crypto-linked equities as bitcoin trades around the mid-$66,000 range. With CORZ still partly tied to crypto economics and investor sentiment around miners, intraday bitcoin weakness is translating into pressure on the stock.

Recent company developments have kept CORZ trading with high beta. Core Scientific put in place a 364-day, $500 million senior secured term-loan facility led by Morgan Stanley (with capacity to expand), aimed at funding data-center development and related energy/real-estate investments that support its shift toward AI-oriented, high-density colocation. In parallel, the company has discussed monetizing substantially all bitcoin reserves during 2026 and disclosed selling roughly 1,900 BTC in January 2026 for about $175 million, framing the proceeds as liquidity to help fund the buildout.

Traders are likely to keep CORZ tightly correlated to bitcoin in the near term, particularly on days when crypto sells off or volatility spikes. The next key catalyst is proof of execution on AI/HPC capacity conversion and financing discipline—investors will look for clearer timing on project deliveries, customer ramp, and whether the funding plan reduces or increases dilution and leverage risk as the company transitions away from bitcoin mining toward contracted infrastructure revenue.